99 related articles for article (PubMed ID: 8014494)
1. Macrophage colony-stimulating factor induction of enhanced macrophage anticryptococcal activity: synergy with fluconazole for killing.
Brummer E; Stevens DA
J Infect Dis; 1994 Jul; 170(1):173-9. PubMed ID: 8014494
[TBL] [Abstract][Full Text] [Related]
2. Effect of macrophage colony-stimulating factor on anticryptococcal activity of bronchoalveolar macrophages: synergy with fluconazole for killing.
Brummer E; Nassar F; Stevens DA
Antimicrob Agents Chemother; 1994 Sep; 38(9):2158-61. PubMed ID: 7811035
[TBL] [Abstract][Full Text] [Related]
3. Macrophage colony-stimulating factor (M-CSF) induction of enhanced anticryptococcal activity in human monocyte-derived macrophages: synergy with fluconazole for killing.
Nassar F; Brummer E; Stevens DA
Cell Immunol; 1995 Aug; 164(1):113-8. PubMed ID: 7634342
[TBL] [Abstract][Full Text] [Related]
4. Anticryptococcal activity of macrophages: role of mouse strain, C5, contact, phagocytosis, and L-arginine.
Brummer E; Stevens DA
Cell Immunol; 1994 Aug; 157(1):1-10. PubMed ID: 8039240
[TBL] [Abstract][Full Text] [Related]
5. Development of macrophage anticryptococcal activity in vitro is dependent on endogenous M-CSF.
Brummer E; Gilmore GL; Shadduck RK; Stevens DA
Cell Immunol; 1998 Nov; 189(2):144-8. PubMed ID: 9790728
[TBL] [Abstract][Full Text] [Related]
6. Effect of in vivo macrophage colony-stimulating factor on fungistasis of bronchoalveolar and peritoneal macrophages against Cryptococcus neoformans.
Nassar F; Brummer E; Stevens DA
Antimicrob Agents Chemother; 1994 Sep; 38(9):2162-4. PubMed ID: 7811036
[TBL] [Abstract][Full Text] [Related]
7. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans.
Collins HL; Bancroft GJ
Eur J Immunol; 1992 Jun; 22(6):1447-54. PubMed ID: 1601035
[TBL] [Abstract][Full Text] [Related]
8. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.
Chen GH; Curtis JL; Mody CH; Christensen PJ; Armstrong LR; Toews GB
J Immunol; 1994 Jan; 152(2):724-34. PubMed ID: 8283047
[TBL] [Abstract][Full Text] [Related]
9. Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole.
Natarajan U; Randhawa N; Brummer E; Stevens DA
J Med Microbiol; 1998 Apr; 47(4):359-63. PubMed ID: 9569003
[TBL] [Abstract][Full Text] [Related]
10. Effect of macrophage colony-stimulating factor (M-CSF) on macrophage morphology, phagocytosis, and intracellular multiplication of Histoplasma capsulatum.
Brummer E; Stevens DA
Int J Immunopharmacol; 1994 Feb; 16(2):171-6. PubMed ID: 8181905
[TBL] [Abstract][Full Text] [Related]
11. Different components in human serum inhibit multiplication of Cryptococcus neoformans and enhance fluconazole activity.
Nassar F; Brummer E; Stevens DA
Antimicrob Agents Chemother; 1995 Nov; 39(11):2490-3. PubMed ID: 8585731
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor and fluconazole enhance anti-cryptococcal activity of monocytes from AIDS patients.
Tascini C; Vecchiarelli A; Preziosi R; Francisci D; Bistoni F; Baldelli F
AIDS; 1999 Jan; 13(1):49-55. PubMed ID: 10207544
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma reduces the capacity of human alveolar macrophages to inhibit growth of Cryptococcus neoformans in vitro.
Reardon CC; Kim SJ; Wagner RP; Kornfeld H
Am J Respir Cell Mol Biol; 1996 Dec; 15(6):711-5. PubMed ID: 8969264
[TBL] [Abstract][Full Text] [Related]
14. Phagocytosis inhibits F-actin-enriched membrane protrusions stimulated by fractalkine (CX3CL1) and colony-stimulating factor 1.
Luo Y; Isaac BM; Casadevall A; Cox D
Infect Immun; 2009 Oct; 77(10):4487-95. PubMed ID: 19620351
[TBL] [Abstract][Full Text] [Related]
15. Synergy of fluconazole with macrophages for antifungal activity against Candida albicans.
Garcha UK; Brummer E; Stevens DA
Mycopathologia; 1995-1996; 132(3):123-8. PubMed ID: 8684425
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-mediated fungistasis: requirement for a macromolecular component in serum.
Granger DL; Perfect JR; Durack DT
J Immunol; 1986 Jul; 137(2):693-701. PubMed ID: 3522734
[TBL] [Abstract][Full Text] [Related]
17. Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing of Candida species.
Garcha UK; Brummer E; Stevens DA
J Infect Dis; 1995 Dec; 172(6):1620-3. PubMed ID: 7594731
[TBL] [Abstract][Full Text] [Related]
18. Study of the role of iron in the anticryptococcal activity of human serum and fluconazole.
Grover DD; Brummer E; Stevens DA
Mycopathologia; 1996; 133(2):71-7. PubMed ID: 8751825
[TBL] [Abstract][Full Text] [Related]
19. Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon gamma on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages.
Baltch AL; Bopp LH; Smith RP; Ritz WJ; Carlyn CJ; Michelsen PB
Diagn Microbiol Infect Dis; 2005 Aug; 52(4):299-304. PubMed ID: 15893901
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro effects of macrophage colony-stimulating factor (M-CSF) on bronchoalveolar macrophages for antihistoplasmal activity.
Khemani S; Brummer E; Stevens DA
Int J Immunopharmacol; 1995 Jan; 17(1):49-53. PubMed ID: 7782153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
